: Following the close of the transaction on May 5, 2021 , GWPH shares were delisted from the NASDAQ. How to Invest in GW Pharmaceuticals' Legacy
Monitor institutional holdings and earnings reports on .
: Integration of GW has diversified Jazz's neuroscience portfolio, with Epidiolex contributing significantly to its revenue. Current Market Data for Jazz Pharmaceuticals (JAZZ) buy gwph stock
: This is the current entity that owns all former GWPH assets and continues to develop its pipeline.
Since GW Pharmaceuticals is now part of , investors interested in its cannabinoid platform—including the blockbuster epilepsy drug Epidiolex —must buy shares of the parent company. : Following the close of the transaction on
As of late April 2026, Jazz Pharmaceuticals continues to trade on the NASDAQ. You can track its performance on major financial platforms: View real-time quotes on . Check analyst ratings and fair value on Investing.com .
: The deal was valued at approximately $7.2 billion . Current Market Data for Jazz Pharmaceuticals (JAZZ) :
Can You Buy GWPH Stock Today? No, you cannot directly purchase stock on the NASDAQ today because GW Pharmaceuticals plc was acquired by Jazz Pharmaceuticals plc in May 2021 .